La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Genetic Therapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Genetic Testing (trends) < Genetic Therapy < Genetic Therapy (ethics)  Facettes :

List of bibliographic references indexed by Genetic Therapy

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000579 (2015) R T Bartus [États-Unis] ; J H Kordower [États-Unis] ; E M Johnson [États-Unis] ; L. Brown [États-Unis] ; B R Kruegel [États-Unis] ; Y. Chu [États-Unis] ; T L Baumann [États-Unis] ; A E Lang [Canada] ; C W Olanow [États-Unis] ; C D Herzog [États-Unis]Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.
000959 (2014) Jackalina M. Van Kampen [Canada] ; David Baranowski [Canada] ; Denis G. Kay [Canada]Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
000E88 (2013) Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
001164 (2012) Daniel Hernandez-Baltazar [Mexique] ; Daniel Martinez-Fong [Mexique] ; Louis-Eric Trudeau [Canada]Optimizing NTS-Polyplex as a Tool for Gene Transfer to Cultured Dopamine Neurons
001610 (2011) James B. Koprich ; Tom H. Johnston ; Philippe Huot ; M. Gabriela Reyes ; Maria Espinosa ; Jonathan M. BrotchieProgressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
002152 (2008) Jon Stoessl [Canada]Potential therapeutic targets for Parkinson's disease.
002154 (2008) Amy M. Todd ; Brian E. StaveleyPink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease.
002759 (2006) H. Ganjavi [Canada] ; M. Gee ; A. Narendran ; N. Parkinson ; M. Krishnamoorthy ; M H Freedman ; D. MalkinAdenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin.
002C03 (2004) Annika Fm Haywood [Canada] ; Brian E. Staveley [Canada]parkin counteracts symptoms in a Drosophila model of Parkinson's disease
003873 (1998) Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Jonathon O. Dostrovsky [Canada]New developments in understanding the etiology of Parkinson's disease and in its treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Genetic Therapy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Genetic Therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Genetic Therapy
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022